Fig. 1 · Structure

Documents & Downloads

Brilanestrant (GDC-0810)

Cat. No. A15958 CAS 1365888-06-7

Estrogen receptor degrader

Brilanestrant (GDC-0810, ARN-810??? is a potent ER-α binder (ER-α, IC50 = 6.1 nM; ER-β, IC50 = 8.8 nM), a full transcriptional antagonist with no agonism and displays good potency and efficacy in ER-α degradation (EC50 = 0.7 nM) and MCF-7 breast cancer cell viability (IC50 = 2.5 nM) assays with good selectivity over other nuclear hormone receptors.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
MCF7 EC50 0.0007 μM Induction of estrogen receptor-alpha degradation in human MCF7 cells after 4 hrs by in-cell western assay [PMID: 25879485]
MCF7 IC50 0.002 μM Cytotoxicity against human MCF7 cells assessed as cell viability after 5 days by CellTiter-Glo assay [PMID: 25879485]
MCF7 EC50 0.7 nM Induction of ERalpha degradation in human MCF7 cells in phenol red free RPMI medium containing 5% charcoal-stripped FBS incubated for 4 hrs by IRDye 800CW/DRAQ5 dye based in-cell Western assay [PMID: 30587451]
MCF7 EC50 0.7 nM Decrease in estrogen receptor alpha level in human MCF7 cells after 4 hrs by in-cell western assay [PMID: 26463130]
MCF7 IC50 0.85 nM Induction of ERalpha degradation in human MCF7 cells after 4 hrs by FITC/Hoechst staining based immunofluorescence imaging analysis [PMID: 32551022]
MCF7 EC50 17 nM Antiproliferative activity against human MCF-7 cells incubated for 72 hrs by Cell-titer Glo assay [PMID: 34251202]
MCF7 IC50 2 nM Antagonist activity at estrogen receptor in human MCF7 cells assessed as inhibition of 17beta-estradiol-mediated transcriptional activation after 24 hrs by luciferase reporter gene assay [PMID: 25879485]
MCF7 IC50 2.5 nM Cytotoxicity against human MCF7 cells assessed as decrease in cell viability after 5 days by celltiterGlo assay [PMID: 26463130]
MCF7 IC50 2.5 nM Antiproliferative activity against human MCF7 cells assessed as reduction in cell proliferation measured after 5 days by Cell-titer-Glo assay [PMID: 30587451]
MCF7 IC50 44 nM Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 72 hrs by Celltiter-Glo assay [PMID: 32551022]

10 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 1365888-06-7
Applications Estrogen receptor degrader
Formula C26H20ClFN2O2
Molecular Weight 446.91
Synonyms RG6046; ARN-810; GDC-0810
SMILES
O=C(O)/C=C/C1=CC=C(C=C1)/C(C2=CC3=C(NN=C3)C=C2)=C(CC)\C4=CC=C(C=C4Cl)F

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 82 mg/mL (183.48 mM)
Water Insoluble
Ethanol 82 mg/mL (183.48 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...